The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable anticipation within the sector. A shift away from Schedule I status, often viewed as outdated and hindering https://bookmark-dofollow.com/story26462839/pot-rescheduling-a-growth-catalyst